Daxibotulinumtoxina

CHEMBL3707359 Phase 4 Disetujui Unknown
Half-Life
Bioavailability
Protein Binding
Molecular Weight
g/mol
LogP
Phase
4

A purified botulinum toxin type A formulation injected into muscles to temporarily reduce their activity. It is used to treat conditions involving abnormal muscle contractions, including cervical dystonia and glabellar lines.

Area Terapeutik

Pharmacokinetics (PK)

Pharmacodynamics (PD)

HBD / HBA

- / -

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Pertanyaan yang Sering Diajukan

A purified botulinum toxin type A formulation injected into muscles to temporarily reduce their activity. It is used to treat conditions involving abnormal muscle contractions, including cervical dystonia and glabellar lines.

Yes, Daxibotulinumtoxina is an approved drug. It has reached clinical phase 4. It is classified as a Unknown.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL3707359. Open-access bioactivity database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-02-27.

Penyangkalan Medis

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.